Patients will be able to find out whether they have genes linked to cancer using a world-leading tool developed by the NHS.

@hopkinskimmel researchers develop novel liquid biopsy approach to identifying early-stage cancers. › ...

Despite major advances in genetic testing for breast cancer risk prediction, death rates remain disproportionately high among ...

Medicare-eligible patients with advanced cancers will have access to genomic tests under a national coverage determination CMS finalized March 16. The determination covers next-generation sequencing ...

For the more than 300,000 women diagnosed with breast cancer each year, one of the biggest challenges is uncertainty around treatment options. Treatment isn’t one-size-fits-all and often comes with ...

An emerging oncology tool known as broad genomic profiling or BGP is increasingly being used to help identify targeted therapies for patients diagnosed with cancer. Rather than analyzing one gene at a ...

They include the “Jolie” gene, named after actress Angelina Jolie, who had preventative surgery after finding out she had a ...

The landscape of metastatic prostate cancer (mPCa) treatment has evolved significantly with the advent of targeted therapies, particularly poly (ADP-ribose) polymerase inhibitors (PARPis). 1 However, ...

We are at a transformative moment in oncology. Remarkable advancements have led to the identification of biomarkers that can predict treatment response, tests that can detect cancer risk before ...

In recognition of February Cancer Prevention Month, jscreen®, the national nonprofit focused on preventing genetic diseases through accessible testing and education, is partnering with Manischewitz® ...

CHENNAI: IIT Madras on Wednesday released a first-of-its-kind cancer genome database covering paediatric leukaemia, ...